Early-stage
HTGF invests in water supply system
High-Tech Gründerfonds has invested €500,000 in water supply measuring system ZIM Plant Technology GmbH.
Business Growth Fund: Myth versus reality
The newest kid on the block – made up of lots of the old boys in the industry – is struggling to make friends. People say the Business Growth Fund (BGF) is too big and too threatening. But is the BGF’s reputation warranted? Kimberly Romaine investigates
Celtic Therapeutics sets up $50m antibody drug company
Celtic Therapeutics has launched an Antibody-Drug-Conjugate (ADC) business, Switzerland-based ADC Therapeutics, with $50m of capital.
Sambrinvest joins €23.6m series-B round in bioscience
Sambrinvest has joined Mitsui Global Investment, Shire, ATMI and the Boehringer Ingelheim Venture Fund to invest €17m in Belgian cell therapy company Promethera Biosciences. The Walloon region has granted a further €6.6m in the form of a loan.
CEE's mid-market boom
CEE activity was subdued but with encouraging signs in 2011. Q1 saw just €1.7bn clocked up, but this was twice the sum of the whole of the previous year. Also, although activity in H2 was quiet, year-end figures nearly doubled to €2.6bn year-on-year.
Imperial Innovations leads £3m funding round in Abingdon Health
Imperial Innovations Group has led a £3m funding round in Abingdon Health, a specialist medical diagnostics company, alongside other private investors.
HTGF invests in MediaMetrics
High-Tech Gründerfonds has invested €500,000 in Berlin-based solution software provider MediaMetrics.
Seventure and Lundbeckfond inject €5m in Enterome
Seventure Partners and Lundbeckfond Ventures have provided French biotech company Enterome with a €5m series-A round of funding.
HTGF invests in hepatitis drug project
High-Tech Gründerfonds and Russian Government-backed Maxwell Biotech Venture Fund have invested in a joint project to develop a drug aimed at the treatment of chronic hepatitis B and D.
I2BF leads £1.8m Seren Photonics funding round
I2BF Global Ventures, Fusion IP and IP Group have invested £1.8m in LED tech company Seren Photonics.
Invercaria and la Caixa back nLife
Invercaria and la Caixa have invested €5m in Granada-based nanomedicine company nLife Therapeutics in exchange for a minority stake.
HTGF leads series-A funding for Bonayou
High-Tech Gründerfonds and "make a startup angel fund" GmbH have invested in PL Gutscheinsysteme's non-cash-gift-voucher card Bonayou.
HTGF and Bayern Kapital back seiratherm
High-Tech Gründerfonds (HTGF), Bayern Kapital and a strategic partner have announced their intention to invest in medical equipment firm seiratherm.
CCMP, Axis and Corpfin back Volotea
CCMP Capital, Axis Participaciones Empresariales and Corpfin Capital have contributed to a €50m funding round to support the launch of Barcelona-based low-cost airline Volotea.
DACH venture scene remains on top form
While the rest of Europe has suffered from a low deal volume in 2011, the DACH early-stage sector is going strong. Considering the well-established venture scene, it is not surprising that this region has dominated early-stage in Q4 2011.
investiere leads series A round for MEDUDEM
investiere, operated by Verve Capital Partners and the Zuercher Kantonalbank have invested CHF 815,000 in medical information provider MEDUDEM.
MKB+ invests €3m in Aeon Astron Europe
Innovatiefonds MKB+ has made the first venture investment in Dutch biotech company Aeon Astron Europe.
Early-stage and Nordics stand out
2011 was a bleak year for the private equity industry, but it was still an improvement on 2010, writes Olivier Marty
High-Tech Gründerfonds backs OakLabs
High-Tech Gründerfonds has invested in German biotech company Oaklabs.
Accel leads $1.5m deal for online payment platform GoCardless
Accel Partners, Passion Capital and YCombinator have injected $1.5m (€1.13m) into British online payment platform GoCardless.
HTGF et al. invest in Conceptboard
High-Tech Gründerfonds and Seedfonds Baden-Württemberg have provided funding for cloud software provider Conceptboard.
Kernel Capital invests €500,000 in Zolkc
Kernel Capital has provided €500,000 of seed funding to tourism technology specialist Zolkc.
Aravis and Proquest back Telormedix
Aravis Venture and Proquest Investments have invested CHF 7.5m in biotechnology company Telormedix.
UK Watch: Bigger not better in Q4
The smaller buyout segment in the UK thrived in Q4 2011 while larger deals faltered, according to the latest findings of the unquote” UK watch, in association with Corbett Keeling.